Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunanda Kane

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
Journal of Medical Economics|May 12, 2025
Cost per remission for mirikizumab versus ustekinumab for moderately to severely active ulcerative colitis treatment from the United States commercial payer perspectiveAnkit Gulati, Neha Mittal, Sunanda Kane, et al.
Inflammatory Bowel Diseases|October 13, 2007
Receipt of preventive health services by IBD patients is significantly lower than by primary care patientsLisbeth Selby, Sunanda Kane, John Wilson, et al.
Inflammatory Bowel Diseases|December 13, 2024
Gender and Sex Differences in Abdominal Pain, Fatigue, And Psychological Symptoms Among Adults with Inflammatory Bowel Disease: A Network AnalysisKendra Kamp, Pei-Lin Yang, Chi-Shan Tsai, et al.
The American Journal of Gastroenterology|September 28, 2004
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's diseaseWilliam J Sandborn, Stephen Hanauer, Edward V Loftus, et al.
Gastroenterology|January 19, 2019
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working GroupUma Mahadevan, Christopher Robinson, Nana Bernasko, et al.
Inflammatory Bowel Diseases|March 2, 2019
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working GroupUma Mahadevan, Christopher Robinson, Nana Bernasko, et al.
Inflammatory Bowel Diseases|April 5, 2019
Erratum: Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working GroupUma Mahadevan, Christopher Robinson, Nana Bernasko, et al.
American Journal of Obstetrics and Gynecology|April 6, 2019
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working GroupUma Mahadevan, Christopher Robinson, Nana Bernasko, et al.
The American Journal of Gastroenterology|January 5, 2013
Quality commitment: the newly established American College of Gastroenterology Quality Council to meet the needs of clinical gastroenterologySunanda Kane, Jonathan Leighton, Costas Kefalas, et al.
Gastroenterology|January 13, 2010
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitisWilliam J Sandborn, Joshua Korzenik, Bret Lashner, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Journal of Medical Economics|May 12, 2025
Cost per remission for mirikizumab versus ustekinumab for moderately to severely active ulcerative colitis treatment from the United States commercial payer perspectiveAnkit Gulati, Neha Mittal, Sunanda Kane, et al.
Inflammatory Bowel Diseases|October 13, 2007
Receipt of preventive health services by IBD patients is significantly lower than by primary care patientsLisbeth Selby, Sunanda Kane, John Wilson, et al.
Inflammatory Bowel Diseases|December 13, 2024
Gender and Sex Differences in Abdominal Pain, Fatigue, And Psychological Symptoms Among Adults with Inflammatory Bowel Disease: A Network AnalysisKendra Kamp, Pei-Lin Yang, Chi-Shan Tsai, et al.
The American Journal of Gastroenterology|September 28, 2004
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's diseaseWilliam J Sandborn, Stephen Hanauer, Edward V Loftus, et al.
Gastroenterology|January 19, 2019
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working GroupUma Mahadevan, Christopher Robinson, Nana Bernasko, et al.
Inflammatory Bowel Diseases|March 2, 2019
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working GroupUma Mahadevan, Christopher Robinson, Nana Bernasko, et al.
Inflammatory Bowel Diseases|April 5, 2019
Erratum: Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working GroupUma Mahadevan, Christopher Robinson, Nana Bernasko, et al.
American Journal of Obstetrics and Gynecology|April 6, 2019
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working GroupUma Mahadevan, Christopher Robinson, Nana Bernasko, et al.
The American Journal of Gastroenterology|January 5, 2013
Quality commitment: the newly established American College of Gastroenterology Quality Council to meet the needs of clinical gastroenterologySunanda Kane, Jonathan Leighton, Costas Kefalas, et al.
Gastroenterology|January 13, 2010
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitisWilliam J Sandborn, Joshua Korzenik, Bret Lashner, et al.
Pageof 16